vs
Side-by-side financial comparison of CorMedix Inc. (CRMD) and CARRIAGE SERVICES INC (CSV). Click either name above to swap in a different company.
CorMedix Inc. is the larger business by last-quarter revenue ($128.6M vs $105.5M, roughly 1.2× CARRIAGE SERVICES INC). CorMedix Inc. produced more free cash flow last quarter ($92.7M vs $6.2M).
CorMedix Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing novel therapeutic products for the prevention and treatment of infectious, inflammatory and cardiorenal diseases. Its lead candidate targets catheter-related bloodstream infections, serving critical care and chronic dialysis patient populations primarily across North America and European markets.
Jardine Cycle & Carriage Limited is the investment holding company of Jardines in Southeast Asia. It is currently 75% held by the conglomerate.
CRMD vs CSV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $128.6M | $105.5M |
| Net Profit | — | $12.3M |
| Gross Margin | 83.4% | 34.8% |
| Operating Margin | 46.0% | 23.3% |
| Net Margin | — | 11.6% |
| Revenue YoY | — | 8.0% |
| Net Profit YoY | — | 24.5% |
| EPS (diluted) | $0.20 | $0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $128.6M | $105.5M | ||
| Q3 25 | $104.3M | $102.7M | ||
| Q2 25 | $39.7M | $102.1M | ||
| Q1 25 | $39.1M | $107.1M | ||
| Q4 24 | — | $97.7M | ||
| Q3 24 | — | $100.7M | ||
| Q2 24 | — | $102.3M | ||
| Q1 24 | — | $103.5M |
| Q4 25 | — | $12.3M | ||
| Q3 25 | $108.6M | $6.6M | ||
| Q2 25 | $19.8M | $11.7M | ||
| Q1 25 | $20.6M | $20.9M | ||
| Q4 24 | — | $9.9M | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | — | $6.3M | ||
| Q1 24 | — | $7.0M |
| Q4 25 | 83.4% | 34.8% | ||
| Q3 25 | 89.3% | 35.3% | ||
| Q2 25 | 95.3% | 35.2% | ||
| Q1 25 | 95.9% | 35.3% | ||
| Q4 24 | — | 34.4% | ||
| Q3 24 | — | 35.2% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 36.0% |
| Q4 25 | 46.0% | 23.3% | ||
| Q3 25 | 49.2% | 17.0% | ||
| Q2 25 | 49.2% | 23.5% | ||
| Q1 25 | 51.5% | 29.5% | ||
| Q4 24 | — | 21.6% | ||
| Q3 24 | — | 22.7% | ||
| Q2 24 | — | 18.0% | ||
| Q1 24 | — | 18.8% |
| Q4 25 | — | 11.6% | ||
| Q3 25 | 104.1% | 6.4% | ||
| Q2 25 | 49.9% | 11.5% | ||
| Q1 25 | 52.8% | 19.5% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | — | 9.8% | ||
| Q2 24 | — | 6.1% | ||
| Q1 24 | — | 6.7% |
| Q4 25 | $0.20 | $0.76 | ||
| Q3 25 | $1.26 | $0.41 | ||
| Q2 25 | $0.28 | $0.74 | ||
| Q1 25 | $0.30 | $1.34 | ||
| Q4 24 | — | $0.62 | ||
| Q3 24 | — | $0.63 | ||
| Q2 24 | — | $0.40 | ||
| Q1 24 | — | $0.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $148.5M | $1.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $405.3M | $254.8M |
| Total Assets | $826.1M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $148.5M | $1.7M | ||
| Q3 25 | $55.7M | $1.2M | ||
| Q2 25 | $190.7M | $1.4M | ||
| Q1 25 | $77.5M | $4.6M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | — | $1.5M | ||
| Q1 24 | — | $1.7M |
| Q4 25 | $405.3M | $254.8M | ||
| Q3 25 | $374.1M | $242.1M | ||
| Q2 25 | $220.6M | $235.4M | ||
| Q1 25 | $114.9M | $223.1M | ||
| Q4 24 | — | $208.6M | ||
| Q3 24 | — | $198.1M | ||
| Q2 24 | — | $187.9M | ||
| Q1 24 | — | $179.6M |
| Q4 25 | $826.1M | $1.3B | ||
| Q3 25 | $750.9M | $1.3B | ||
| Q2 25 | $252.6M | $1.3B | ||
| Q1 25 | $149.6M | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $94.5M | $14.1M |
| Free Cash FlowOCF − Capex | $92.7M | $6.2M |
| FCF MarginFCF / Revenue | 72.1% | 5.9% |
| Capex IntensityCapex / Revenue | 1.3% | 7.5% |
| Cash ConversionOCF / Net Profit | — | 1.15× |
| TTM Free Cash FlowTrailing 4 quarters | $172.8M | $40.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $94.5M | $14.1M | ||
| Q3 25 | $30.9M | $24.7M | ||
| Q2 25 | $30.0M | $8.1M | ||
| Q1 25 | $19.7M | $13.8M | ||
| Q4 24 | — | $9.3M | ||
| Q3 24 | — | $20.9M | ||
| Q2 24 | — | $2.2M | ||
| Q1 24 | — | $19.7M |
| Q4 25 | $92.7M | $6.2M | ||
| Q3 25 | $30.4M | $18.0M | ||
| Q2 25 | $30.0M | $5.2M | ||
| Q1 25 | $19.7M | $10.6M | ||
| Q4 24 | — | $4.9M | ||
| Q3 24 | — | $16.2M | ||
| Q2 24 | — | $-1.4M | ||
| Q1 24 | — | $16.2M |
| Q4 25 | 72.1% | 5.9% | ||
| Q3 25 | 29.1% | 17.5% | ||
| Q2 25 | 75.4% | 5.1% | ||
| Q1 25 | 50.5% | 9.9% | ||
| Q4 24 | — | 5.0% | ||
| Q3 24 | — | 16.1% | ||
| Q2 24 | — | -1.4% | ||
| Q1 24 | — | 15.6% |
| Q4 25 | 1.3% | 7.5% | ||
| Q3 25 | 0.5% | 6.5% | ||
| Q2 25 | 0.1% | 2.8% | ||
| Q1 25 | 0.0% | 3.0% | ||
| Q4 24 | — | 4.5% | ||
| Q3 24 | — | 4.6% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | — | 3.4% |
| Q4 25 | — | 1.15× | ||
| Q3 25 | 0.28× | 3.76× | ||
| Q2 25 | 1.51× | 0.69× | ||
| Q1 25 | 0.96× | 0.66× | ||
| Q4 24 | — | 0.94× | ||
| Q3 24 | — | 2.11× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 2.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRMD
| Acquisition Of Melinta | $52.9M | 41% |
| Melinta Portfolio | $45.5M | 35% |
| Other | $18.6M | 14% |
| Contract Revenue | $7.4M | 6% |
| BARDA Agreement | $4.2M | 3% |
CSV
| Propertyand Merchandise | $47.8M | 45% |
| Cemetery Interment Rights | $24.8M | 23% |
| Merchandise | $18.9M | 18% |
| Other Revenue | $10.2M | 10% |
| Other | $3.9M | 4% |
